Ontology highlight
ABSTRACT: Background
Antibody-mediated rejection is an important cause of kidney transplant loss. A new strategy requiring application of precision medicine tools in transplantation considers molecular compatibility between donors and recipients and holds the promise of improved immunologic risk, preventing rejection and premature graft loss. The objective of this study was to gather Canadian transplant professionals' perspectives on molecular compatibility in kidney transplantation.Methods
Seventeen Canadian transplant professionals (14 nephrologists, 2 nurses, and 1 surgeon) participated in semistructured interviews in 2021. The interviews were digitally recorded, transcribed, and analyzed using the qualitative description approach.Results
Participants identified fair acces
SUBMITTER: Affdal A
PROVIDER: S-EPMC10727564 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature